This episode replays some of a round table we held at JP Morgan, back when people used to travel... It features the voices of Mike Rea, in conversation with Linda Avey, Co-founder of 23andMe, and Curious, Inc, Amrit Chaudhuri, CEO, Mass Innovation Labs (now SmartLabs), Steve Holtzman, then CEO, Decibel Therapeutics, Raj Kannan then SVP, Global Franchise Head, Neurology & Immunology, EMD Serono, Michael Schrage, Research Fellow, MIT Center for Digital Business; Visiting Fellow, Imperial College Department of Innovation and Entrepreneurship, and Robert Urban, then Global Head, Johnson & Johnson Innovation

Do head to our YouTube channel for more from this round table, and to see which voice belongs to which speaker...

This episode replays some of a round table we held at JP Morgan, back when people used to travel... It features the voices of Mike Rea, in conversation with Linda Avey, Co-founder of 23andMe, and Curious, Inc, Amrit Chaudhuri, CEO, Mass Innovation Labs (now SmartLabs), Steve Holtzman, then CEO, Decibel Therapeutics, Raj Kannan then SVP, Global Franchise Head, Neurology & Immunology, EMD Serono, Michael Schrage, Research Fellow, MIT Center for Digital Business; Visiting Fellow, Imperial College Department of Innovation and Entrepreneurship, and Robert Urban, then Global Head, Johnson & Johnson Innovation Do head to our YouTube channel for more from this round table, and to see which voice belongs to which speaker...

This episode replays some of a round table we held at JP Morgan, back when people used to travel... It features the voices of Mike Rea, in conversation with Linda Avey, Co-founder of 23andMe, and Curious, Inc, Amrit Chaudhuri, CEO, Mass Innovation Labs (now SmartLabs), Steve Holtzman, then CEO, Decibel Therapeutics, Raj Kannan then SVP, Global Franchise Head, Neurology &amp; Immunology, EMD Serono, Michael Schrage, Research Fellow, MIT Center for Digital Business; Visiting Fellow, Imperial College Department of Innovation and Entrepreneurship, and Robert Urban, then Global Head, Johnson &amp; Johnson Innovation

Do head to our YouTube channel for more from this round table, and to see which voice belongs to which speaker...

IDEA Collider | Defining and Measuring Innovation

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.

Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.

Questions We Explore

* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?


🎧 Listen and subscribe on all major platforms.

Business

Science

Marketing

Management

Life Sciences

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking. Questions We Explore * What is asymmetric learning, and how does it fuel pharma innovation? * Why do some organizations outpace others—and what can we learn from them? * How can we overcome barriers to meaningful progress in healthcare? * What’s broken in traditional innovation models—and how do we fix it? 🎧 Listen and subscribe on all major platforms.

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.

Each episode dives into how organizations can make smarter decisions earlier, reimagine R&amp;D, and unlock competitive advantage through differentiated thinking.

Questions We Explore

* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?


🎧 Listen and subscribe on all major platforms.

Share IDEA Collider | Defining and Measuring Innovation

Sign up to save your podcasts

IDEA Collider | Defining and Measuring Innovation

IDEA Collider | Defining and Measuring Innovation

More shows like IDEA Collider: Innovation & Asymmetric Learning in Pharma

Odd Lots

The Daily

The Readout Loud

FT News Briefing

The Journal.

BioCentury This Week

People I (Mostly) Admire

The Ezra Klein Show

Biotech Hangout

The Rest Is Politics

The Top Line

The Rest Is Politics: US

The BioCentury Show

The Economics Show

Cures & Capital